Date: Tuesday 25 October, 2022 & Wednesday 26 October, 2022
Location: Abuja, Nigeria
Hybrid Meeting: In-person & Online
The WHO R&D Blueprint Team and Coalition for Epidemic Preparedness Innovations (CEPI) together with the co-hosting partner organisations Nigeria Centre of Disease Control (NCDC) and Africa Centres for Disease Control and Prevention (ACDC), are organising a workshop on "Accelerating the licensure of Lassa vaccines Generating robust evidence on vaccine efficacy and safety".
The workshop will bring together Lassa fever disease experts, epidemiologists, clinical researchers, public health and regulatory authorities, vaccine developers as well as many other experts in the field.
The objectives of the workshop are:
- To discuss Lassa virus disease, epidemiology and immunology.
- To present current vaccine candidates under development.
- To outline the design options for clinical efficacy trials for Lassa vaccines.
- To develop a collaborative approach with key stakeholders to advance Lassa vaccine development and evaluation.
Registration Link: https://who-e.zoom.us/webinar/register/WN_BulnSUmGQAepQn_ru92Dkw
LIVE STREAM